BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34890096)

  • 1. Successful treatment of erythema nodosum leprosum with apremilast.
    Abril-Pérez C; Palacios-Diaz RD; Navarro-Mira MÁ; Botella-Estrada R
    Dermatol Ther; 2022 Mar; 35(3):e15258. PubMed ID: 34890096
    [No Abstract]   [Full Text] [Related]  

  • 2. Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab and apremilast: A case report.
    Mengeot L; Jachiet M; Bourrat E; Mahé A; Cambau E; Bernard E; Pasqualini C; Chamouine A; Truong J; Dumaine C; Bertolotti A; Franco J
    J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):e244-e246. PubMed ID: 37795664
    [No Abstract]   [Full Text] [Related]  

  • 3. Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times.
    Sachdeva S; Sardana K; Kumari R; Bhogar K; Khurana A; Malhotra P
    Int J Dermatol; 2022 Nov; 61(11):e441-e443. PubMed ID: 35405022
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythema nodosum leprosum successfully treated with apremilast: more effective and safer than classic treatments?
    Sánchez-Martínez EM; Melgosa-Ramos FJ; Moneva-Léniz LM; Gegúndez-Hernández H; Prats-Máñez A; Mateu-Puchades A
    Int J Dermatol; 2021 Feb; 60(2):e74-e76. PubMed ID: 32970828
    [No Abstract]   [Full Text] [Related]  

  • 5. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study.
    Narang T; Ashraf R; Kaushik A; Dogra S
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e917-e919. PubMed ID: 34365679
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent erythema nodosum leprosum leading to secondary renal amyloidosis and nephrotic syndrome in an Indian patient with lepromatous leprosy.
    Ahuja R; Garg S; Barwad A; Subbiah A; Gupta V
    Int J Dermatol; 2023 Sep; 62(9):e514-e517. PubMed ID: 37066445
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.
    Gupta SK; Kumari S
    An Bras Dermatol; 2022; 97(1):49-53. PubMed ID: 34848113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.
    Narang T; Kaushik A; Dogra S
    Br J Dermatol; 2020 Apr; 182(4):1034-1037. PubMed ID: 31218666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects.
    Alakad R; Nofal A; Assaf M
    J Dtsch Dermatol Ges; 2021 Aug; 19(8):1133-1143. PubMed ID: 34033221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in erythema nodosum leprosum.
    Jew LJ; Middleton RK
    DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on "Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon".
    Prestigiacomo JF; Scollard DM
    Am J Dermatopathol; 2019 Mar; 41(3):239. PubMed ID: 30801346
    [No Abstract]   [Full Text] [Related]  

  • 13. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of the retreatment of patients with multibacillary leprosy and episodes of erythema nodosum leprosum and/or persistent neuritis: a single-center experience.
    Lastória JC; Almeida TSC; Putinatti MSMA; Padovani CR
    An Bras Dermatol; 2018 Mar; 93(2):181-184. PubMed ID: 29723371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An uncommon variant of erythema nodosum leprosum responding well to methotrexate: Report of two cases.
    Rani S; Singh S; Agrawal D; Sardana K; Ahuja A
    Trop Doct; 2021 Oct; 51(4):569-572. PubMed ID: 34102925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Our experience of the use of thalidomide in the steroid-dependent severe erythema nodosum leprosum.
    Chaudhry NS; Rath SR; Visvanath V; Torsekar RG
    Indian J Dermatol Venereol Leprol; 2009; 75(2):189-90. PubMed ID: 19293514
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrotic erythema nodosum leprosum as the first manifestation of borderline lepromatous leprosy.
    Tourlaki A; Marzano AV; Gianotti R; Fiallo P; Nunzi E; Alessi E
    Arch Dermatol; 2008 Jun; 144(6):818-20. PubMed ID: 18559789
    [No Abstract]   [Full Text] [Related]  

  • 20. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
    Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
    Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.